2022-11-15
2022-12-11
2022-11-25
2022-11-17
2022-11-22
2022-11-21
2022-11-15
2022-11-21
2023-05-10
2023-04-10
2023-05-06
2023-05-23
脑内基因治疗,首批受试患者预后良好,将在今年内推动FDA注册进程
2023-01-26
2023-01-27
2023-09-19
“基因编辑第一股”百奥赛图启动科创板IPO辅导,布局抗体药物开发全产业链
2023-01-03